Kiora Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule,…

Biotechnology
US, Salt Lake City [HQ]

News

Theses · Events · Sentiments
End of KPRX's Analysis
CIK: 1372514 CUSIP: 49721T101 ISIN: US49721T3095 LEI: - UEI: -
Secondary Listings
KPRX has no secondary listings inside our databases.